Looks like you’re on the UK site. Choose another location to see content specific to your location
On strict precautionary measures, Leo Pharma has recalled its Picato (Ingenol Mebutate) stock, due to the concerns of potential hazards to skin malignancy. All healthcare professionals, that stock Picato, have been instructed to quarantine and return all remaining stock to the manufacturer.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard
